 |
BioWorld-International-2008-02-13
Gene Variant Discoveries May Speed Prostate Cancer Tests
No Funding to be Found; Hunter-Fleming is Acquired
LONDON - Another UK biotech bit the dust as Hunter-Fleming Ltd. was acquired by Newron Pharmaceuticals SpA in an all share transaction, after trying for a year, and failing, to raise fresh capital on its own account. (BioWorld International)